Semaglutide SM20 20mg*10vials

Smegglutide SM20 20mg x 10 Vials

Product Overview

Smegglutide SM20 is a high-purity long-acting lyophilized GLP-1 receptor agonist developed specifically for advanced preclinical metabolic laboratory research. As an upgrade to the SM10 and SM15 series, SM20 features second-generation molecular structure optimization, supporting higher target binding activity, stronger antioxidant and anti-degradation properties, and longer in vivo metabolic persistence research. Its high 20mg concentration per vial supports high-dose gradient screening, long-term continuous metabolic modeling, large-scale batch sample validation, and high-standard data repeatability testing experimental requirements, serving as a high-quality core research raw material for in-depth research on GLP-1 mechanisms and high-dose efficacy.

Core Research Functions

Optimized GLP-1 Single-Target Activation Characteristics and Human Incretin Physiological Effects Stable Mimicry: Supports optimized GLP-1 single-target activation characteristics research, human incretin physiological effects stable mimicry studies.

High-Dose Insulin Resistance Improvement and Glycemic Homeostasis Long-Term Regulation: Supports high-dose insulin resistance improvement core mechanisms exploration research, glycemic homeostasis long-term regulation studies, and glucose and lipid metabolism pathways remodeling research.

Appetite-Suppressing Signals Effective Activation and Satiety Cycle Significant Prolongation: Supports appetite-suppressing signals effective activation research, satiety cycle significant prolongation studies, excessive energy intake reduction related studies, and systemic lipid metabolism and fat accumulation deep intervention research.

Stronger Biological Activity and More Durable Experimental Effects: Supports stronger biological activity, more durable experimental effects, and more significant high-dose phenotypic differences research compared with the low- and medium-dose versions of SM10 and SM15.

More Authoritative Stable Data Support for In-Depth Research: Supports more authoritative stable data provision research for in-depth research on severe metabolic disorders, chronic endocrine diseases, and mechanisms related to high-dose efficacy.

Smegglutide SM20, based on its optimized GLP-1 single-target activation characteristics, supports human incretin physiological effects stable mimicry research. In professional laboratory research, SM20 is mainly used to explore high-dose insulin resistance improvement, glycemic homeostasis long-term regulation, and glucose and lipid metabolism pathways remodeling core mechanisms. It supports appetite-suppressing signals effective activation research, satiety cycle significant prolongation studies, excessive energy intake reduction related studies, and systemic lipid metabolism and fat accumulation deep intervention research. Compared with the low- and medium-dose versions of SM10 and SM15, SM20 supports stronger biological activity, more durable experimental effects, and more significant high-dose phenotypic differences research, providing more authoritative stable data support for in-depth research on severe metabolic disorders, chronic endocrine diseases, and mechanisms related to high-dose efficacy.

Core Product Advantages

SM20 Advanced Upgrade: Second-generation optimized molecular structure effectively supports target binding activity and molecular stability enhancement research. Compared with ordinary semaglutide, SM10, and SM15, SM20 supports stronger anti-degradation capabilities and a longer effective duration research, ensuring more stable and discriminative high-dose experimental results research.

20mg High-Purity High Concentration: The concentration is twice that of the conventional 10mg specification and 1.3 times that of the 15mg specification. Suitable for high-dose gradient control experiments, long-term repetitive animal model construction, and large-scale parallel sample testing, supporting frequent dilution and solution changes caused experimental errors significant reduction related research.

Advanced Vacuum Lyophilization Process: Employing aseptic high-purity lyophilization technology to support peptide biological activity stable retention research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis COA, supporting extremely low impurity content and excellent batch consistency research.

Standard 10-Bottle Box Bulk Packaging: Each box contains 10 bottles in integrated aseptic packaging, suitable for long-term laboratory storage, high-end drug preclinical research, key university research projects, and global bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 20mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.